Causal relevance of major lipids for stroke subtypes: evidence from CKB
Zhengming CHEN, University of Oxford
Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK
CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, CAS
Time: April 23, Monday, 2018, 10:00 am
Venue: Mingde Lecture Hall
2nd Floor, Building A, Shanghai Information Center for Life Sciences, CAS, 319 Yue Yang Road, Shanghai
Brief Biography of Speaker:
Director of the China Programs at the Oxford University’s Clinical Trial Service Unit and Epidemiological Studies Unit; Co-PI in UK of China Kadoorie Biobank(CKB). His main research areas involve large randomized trials of widely practicable treatments for chronic diseases (such as stroke, heart disease and cancer), the environmental and genetic causes of chronic disease as well as efficient strategies for chronic disease control in developing countries. Over the past 20 years, he has initiated and led several large randomized trials in heart disease (50,000 patients), acute stroke (20,000 patients), cancer (15,000 patients) and 3 cohort studies involving more than 750,000 individuals. He has published over 250 research papers, with many in the top rank journals such as Lancet, JAMA, NEJM, Nature Medicine and BMJ, and also sits on various research committees. For more information about Prof. Zhengming CHEN, please visit https://www.ndph.ox.ac.uk/team/zhengming-chen .